drugset / Trial / NCT01070979

Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.

NCT01070979

Phase 3 Completed 249 enrolled Warner Chilcott
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Multicenter, double-blind, controlled, parallel group, randomized study to compare the clinical benefit of Estradiol acetate tablets, estradiol tablets and conjugated equine estrogen tablets, each administered orally, once daily, to postmenopausal women.

Timeline

Start
2003-02
Primary completion
2003-09
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator ESTROGENS, CONJUGATED Unknown 0.625 mg Oral
Comparator Estradiol Other / unclassified 0.9 mg Oral
Comparator Estradiol Other / unclassified 1 mg Oral

Indications

No indication recorded.